The Global Biologics Market Growth is driven by Rising Prevalence of Chronic Diseases

The Global Biologics Market is estimated to be valued at US$ 463.06 Bn in 2024 and is expected to exhibit a CAGR of 8.2% over the forecast period 2024 to 2031.

The growth can be attributed to rising prevalence of chronic diseases worldwide along with growing geriatric population susceptible to various diseases. Biologics have revolutionized the treatment of chronic diseases owing to their high specificity and targeted approach.